NCT05314270

Brief Summary

To study the etiologies of patients diagnosed as non-B, non-C liver cirrhosis (NBNC-LC). To describe the different patient's outcomes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 6, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

April 6, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

March 29, 2022

Last Update Submit

March 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Detection of different etiologies of liver cirrhosis that not related to HBV or HCV in our community

    Base line

Secondary Outcomes (1)

  • Detection of the most common etiologies of Non B Non C liver cirrhosis in our community

    Baseline

Interventions

Diagnostic testsDIAGNOSTIC_TEST

Diaagnostic tests for all pt diagnosed as Non-B Non-C Liver Cirrhosis

Also known as: 24h copper in urine.. Iron profile.. Liver biopsy

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017\_2023

You may qualify if:

  • All pateints diagnosed as Non-B Non-C Liver Cirrhosis in the period from 2017\_2023

You may not qualify if:

  • We will exclude the pateints that will be diagnosed as HBV-HCV induced Liver Cirrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Diagnostic Tests, Routine

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Central Study Contacts

Abdelrahman Mohammed Abdelrahman Morsi

CONTACT

Magda Shehata Hassan

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 29, 2022

First Posted

April 6, 2022

Study Start

October 1, 2022

Primary Completion

October 1, 2023

Study Completion

November 1, 2023

Last Updated

April 6, 2022

Record last verified: 2022-03